0000059478-22-000026.txt : 20220203 0000059478-22-000026.hdr.sgml : 20220203 20220203165502 ACCESSION NUMBER: 0000059478-22-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220201 FILED AS OF DATE: 20220203 DATE AS OF CHANGE: 20220203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fry Stephen F CENTRAL INDEX KEY: 0001513324 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 22589406 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER CITY: INDIANAPOLIS STATE: IN ZIP: 46285 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ELI LILLY & Co CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 FORMER COMPANY: FORMER CONFORMED NAME: LILLY ELI & CO DATE OF NAME CHANGE: 19941024 4 1 wf-form4_164392526851459.xml FORM 4 X0306 4 2022-02-01 0 0000059478 ELI LILLY & Co LLY 0001513324 Fry Stephen F LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 0 1 0 0 SVP, HR & Diversity Common Stock 2022-02-01 4 M 0 10170 0 A 144846 D Common Stock 2022-02-01 4 F 0 4554 245.39 D 140292 D Common Stock 181 I 401(k) Restricted Stock Unit 2022-02-01 4 M 0 10170 0 D 2022-02-01 2022-02-01 Common Stock 10170.0 0 D Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. /s/ Jonathan Groff for Stephen F. Fry, pursuant to attached authorization 2022-02-03 EX-24 2 frypoa.htm FRY_POA

Stephen F. Fry
Lilly Corporate Center
Indianapolis, Indiana 46285



Securities and Exchange Commission
Washington, D.C.  20549

Authorization Regarding Reporting Forms

I hereby authorize and designate the following persons to sign and file with the Commission on my behalf Forms 3, 4, and 5 (including any amendments thereto) covering my transactions and holdings in the common stock and other equity securities of Eli Lilly and Company as required by Section 16 of the Securities Exchange Act of 1934 and the rules thereunder:

    Anat Hakim, Lilly Corporate Center, Indianapolis, Indiana

    Erin Conway, Lilly Corporate Center, Indianapolis, Indiana

    Jonathan Groff, Lilly Corporate Center, Indianapolis, Indiana

This authorization and designation shall remain in effect until a written revocation is signed by me and provided to the Commission.

Date: August 11, 2021

/s/ Stephen F. Fry